houses in rural areas (Mott et al. 1978) , Triatoma infestans in South America, Rhodnius prolixus in Venezuela, Colombia and Central America (Schofi eld and Dias 1999), and Triatoma barberi in Mexico (Guzman 2001) , are the most common species responsible for transmission. Improvements in housing conditions and vector control measures instituted by the Southern Cone Initiative in 1991 have contributed to a decline in transmission in endemic countries (Schofi eld and Dias 1999) . However, concern remains that reinfestation of homes by secondary sylvatic vectors, e.g. Triatoma sordida, will compromise the long-term effi cacy of vector control measures in Brazil and other Southern American countries (Monteiro et al. 2001 , WHO 2002 . Blood transfusion and organ transplantation represent further routes of T. cruzi transmission. Although many countries in Latin America screen blood donations for T. cruzi, infection rates ranging from 0.1% to 24.4% are estimated to occur through transfusion (WHO 2002) .
In the U.S., vector-transmitted human infections have been reported in the southern States (Ochs et al. 1996 , Herwaldt et al. 2000 . Several studies have shown the presence of the insect vector as well as infection of domestic dogs and wild animals in the US (Meurs et al. 1998 , Bradley et al. 2000 , Beard et al. 2003 , Yabsley and Noblet 2002 . Further, due to signifi cant increases in immigration to the USA and Canada from endemic countries and perinatal transmission, it is estimated that ∼ 100, 000 people residing in USA may be infected with T. cruzi. Currently, the US does not screen blood donations, as no approved screening test is available (Dodd and Leiby 2004) . These conditions, taken together, could contribute to the transmission of T. cruzi by blood-borne, congenital, and to a lesser extent, vector-borne routes, indicating the potential for the emergence of Chagas disease as a disease of public health importance in the USA (Leiby et al. 2000, Dodd and Leiby 2004) .
CHAGASIC DISEASE

CLINICAL SYMPTOMS
Infection by T. cruzi elicits acute non-specifi c symptoms e.g. fever, malaise, edema and/or enlarged liver or spleen to the characteristic swelling at the site of entry-a chagoma (of the skin), or Romana's sign (of the conjuctiva or eyelid). In spite of the high blood parasitemia in the acute phase, clinical symptoms do not warranty hospital visit, and therefore, anti-parasitic treatment is often not initiated. In few (<5%) acute patients, sudden death due to congestive heart failure associated with myocarditis or meningoencephalitis may occur. The majority of patients enter an " indeterminate" phase that is defi ned by the presence of T. cruzi specifi c antibodies but the absence of clinical signs of cardiac abnormalities. Between 10-30 years after initial infection, an estimated 30-40% of " indeterminate" patients show recognizable signs and/or symptoms of a unique form of heart disease referred to as chagasic cardiomyopathy (CCM).
Generally, patients develop a complex constellation of symptoms and signs; their presence or absence and severity have been used to create a diagnostic scale for CCM (Rocha et al. 2003) . The non-specifi c symptoms suggestive of heart problems include palpitations, dizziness, and syncope. Clinical manifestations of CCM are congestive heart failure, thromboembolism in brain, limbs or lungs, and ventricular fi brillation (Rassi et al. 2000) . The principal defects in the conduction system present as a mixture of arrhythmias -e.g. tachycardia, bradycardia, ventricular fi brillation -and electrical impulse blockages -e.g. right bundle branch and left anterior fasicle block. These are identifi ed by electrocardiography as well as via 24-hour Holter monitoring or stress (exercise) testing (Elizari 2002) . Myocardial defects, that is, impairment in the architecture of the heart muscle, are mainly cardiomegaly with hypertrophy and dilation of the chambers; and aneurism, particularly in the apical portion of the left ventricle, which may rupture. These attributes can be identifi ed via echocardiography and chest X-ray and are frequently observed at autopsy. Clinical manifestations of CCM may also be correlated with defective innervation and defective contraction within the myocardium. Pathogenic changes in the parasympathetic branch of the autonomic nervous system are sometimes observed at autopsy (Koberle 1968 , Mott and Hagstrom 1965 , Oliveira 1985 . Specifi cally, a reduction -or in some cases, a complete absence -of cells in the neuronal ganglia has been described and may be indicative of a role for impaired heart innervation in development of CCM (Marin-Neto 1998) . Further, the basement membrane of the myocardial capillaries is abnormally thick, suggestive of microcirculation defects (Rossi et al. 2003) . Summariz-ing, the dilation and hypertrophy of the left ventricle combined with fi brosis at its apex are considered pathognomonic of CCM, while the distinctive clinical syndrome described above accounts for heart failure and subsequent death that occurs in chagasic patients.
PATHOLOGY
Several specifi c heart changes -at the gross and microscopic levels -are distinguishing in CCM. At autopsy, the most commonly observed abnormalities in the heart structure are global (biventricular) heart enlargement, apical aneurism, dilation/ thinning and thrombi of the heart walls (Rossi et al. 2003) . The histological examination of sections from both autopsy and biopsy specimens revealed tissue fi brosis, inflammation, and hypertrophy of cardiac fi bers are the chief pathological consequences of chagasic heart disease. Fibrosis is most pronounced in the left ventricle and apex. This varies in severity and its location may be interstitial and/or diffuse. It corresponds to increased collagen fi ber deposition around the muscle bundles that resembles reparative fi brosis resulting from microinfarction. These microscopic observations bear relationship to the gross pathological observations of heart enlargement of the hypertrophic and dilated form.
PATHOGENIC MECHANISMS (HISTORICAL PERSPECTIVE)
Extensive studies utilizing human biopsy and autopsy specimens-and experimental investigations have provided data on the clinical and pathological manifestations of chagasic disease. However, the mechanism(s) leading up to CCM remain uncertain. There is currently no universally accepted model to predict which individuals in the " indeterminate" phase will progress to chronic chagasic disease. Several fundamental enigmas remain unresolved. First, why does the parasite, which is shown to infect a wide variety of organs and cell types, primarily cause disease in the heart? Second, why does only a subset of infected (seropositive) individuals progress to CCM? Third, what accounts for the long latency period between infection and appearance of heart disease? Nevertheless, a signifi cant body of literature supports the hypothesis that immune responses, consistently triggered by parasite persistence or by the host response to selfantigens (autoimmunity) or both play a role in the development and/or propagation of pathological lesions. The concept of parasite persistence is that a few persisting parasites continually trigger immune responses, leading to chronic inflammation and cell death. Alternatively, the concept of autoimmunity is that the parasite has antigens that mimic the human host. In effort to control T. cruzi infection, the host produces antibodies and T cells that subsequently recognize self-antigens, and destroy the myocardial tissue.
PARASITE PERSISTENCE
Several lines of evidence establish that a low level of parasites remain in the blood and/or the heart tissue. First, direct detection in autopsy specimens and myocardial biopsies has been possible using new methods e.g. immunohistochemical and immunofluorescence techniques (Mortara et al. 1999 , Higuchi et al. 2003 and PCR (Jones et al. 1993 , Salomone et al. 2000 , including in situ PCR (Jones et al. 1992) . Second, in chronically infected individuals, the reactivation of acute disease, particularly meningoencephalitis, that occurs following immunosuppression due to AIDS (Rocha et al. 1994 , Sartori et al. 1995 or drug therapy (Jardim and Takayanagui 1994, D'Almeida et al. 1996) illustrates that parasites persist in previously undiagnosed individuals for years after initial infection. Thirdly, transmission of T. cruzi can occur via blood transfusion and transplantation of infected organs obtained from asymptomatic individuals (Leiby et al. 2000) . Finally, parasite persistence would explain the clinical benefi t of anti-parasitic drug treatment in chronic infection, which has been observed in a limited number of studies (Andrade et al. 1992 , Viotti et al. 1994 . Altogether, these studies support the concept of parasite persistence and its likely pathologic role in CCM development.
IMMUNE RESPONSES: PROTECTIVE OR PATHOLOGICAL
Sterilizing immunity does not appear to exist in T. cruzi infection. Nevertheless, the immune response that is mounted against T. cruzi after initial infection is capable of controlling the parasite, as evidenced by the eventual resolution of acute parasitemia. As mentioned above, these immune responses may contribute to pathology through either or a combination of two general mechanisms: i) a process of autoimmune destruction of host cardiac tissue (autoimmune hypothesis) or ii) through specifi c mediators of the immune response to T. cruzi itself or to its antigenic components that linger in the tissues (parasite persistence hypothesis).
Experimental studies
Assorted experimental approaches using animal and tissue culture models of T. cruzi infection and disease have provided a portrait of the immune response to T. cruzi infection. In addition, various knockout or immunocompromised animals have been utilized to dissect the relative contribution of different features of the immune response that mediate protection versus pathology. Briefly, in acutely infected animals (mice and rats), it is shown that macrophages (Mφ) and natural killer (NK) cells provide the fi rst line of defense (Nogueira and Cohn 1978) . T. cruzi elicits IFN-γ production by NK cells, activating Mφ (Torrico et al. 1991 , Gazzinelli et al. 1992 . In turn, Mφ produce TNF-α, inducing nitric oxide (NO), which is toxic to parasites in vitro (Vespa et al. 1994 , Martins et al. 1998 ). Interestingly, GPI-anchored macromolecules, abundantly expressed by the infective and intracellular stages of the parasite, have been characterized as the prime inducers of the proinflammatory cytokines (e.g. TNF-α, IL-1 and IL-6) and chemokines (e.g. IP-10, MCP-1, MIG, and RANTES) that may be key regulators of the innate and adaptive immune responses responsible for the control of acute infection. CD4
+ T cells assist in the control of T. cruzi through secretion of Th1 cytokines, amplifi cation of phagocytic activity of macrophages, and stimulation of B cell proliferation and antibody production (Aliberti et al. 1996, Brener and Gazzinelli 1997) . CD8 + T cells are shown to exhibit specifi c cytotoxicity in vitro in response to T. cruzi-expressed antigens (Garg et al. 1997 , Wizel et al. 1997 , Garg and Tarleton 2002 and are suggested to control T. cruzi either by cytolysis of the infected cells or by secretion of Th1 cytokines that induce trypanocidal activity. Altogether, these studies conclude that an effi cient protective response to acute parasitemia is provided by Th1 cytokines, lytic antibodies and the concerted activities of macrophages, T helper cells and cytotoxic T lymphocytes. With progression to indeterminate -chronic phase, parasite nests are not detectable by conventional histological analysis. However, a low level of inflammatory response constituted by macrophages and CD8 + T lymphocytes persist in the heart. Although often they are not associated with amastigote nests or trypomastigotes, T. cruzi antigens may be present (Higuchi 1995 , Reis et al. 1997 . CD4 + T cells, though less prominent in the chronic stage, are suggested to be associated with myocyte death and increased animal mortality (Soares et al. 2001) and appear to represent an autoreactive phenotype that contributes to tissue destruction (Soares and Santos 1999) . At this later stage, continued production of IFN-γ and IL-2 is believed to stimulate lytic antibody production by B cells (Brener and Gazzinelli 1997) . Several investigators have utilized mice treated with antibody to immune mediators and murine models in which genes for various immune mediators have been deleted to evaluate the signifi cance of inflammatory response in chagasic disease. These include mice defi cient in inducible NO synthase (iNOS), IFN-γ , TNF-α, TNF-α receptor, and CD4 + and/or CD8 + T cells (Minoprio et al. 1987 , Tarleton 1990 , Tarleton et al. 1992 , Bachmaier et al. 1997 , Martins et al. 1998 , Aliberti et al. 2001 , Chandra et al. 2002 . The overall observation from these studies is that despite a general increase in parasite burden, the extent of cell death and tissue damage are diminished in mice defi cient in inflam-matory mediators compared to the wild-type controls, thus suggesting the pathological signifi cance of persistent inflammation in chagasic disease.
Human studies
Many of the above experimental observations agree with the more limited number of human studies. In acute infection, hypergammaglobulinemia occurs and the continued presence of antibody is used to diagnose infection with T. cruzi. In human patients' cardiac biopsies, among the mononuclear cells, macrophages and CD8 + T cells represent the majority of the infi ltrate (Higuchi et al. 1997) . IFN-γ can be detected in tissues via in situ immunohistochemistry (Bahia-Oliveira et al. 1998 , Correa-Oliveira et al. 1999 ) and appears to be correlated with the presence of CD8 + T cells (Higuchi et al. 1997 , Reis et al. 1997 ). In addition, T. cruzispecifi c human CTL have been identifi ed (Thomson et al. 1998 , Wizel et al. 1998 . While parasites are rarely seen in cardiac tissue, pseudocysts are associated with relatively sparse infi ltrate of IL-2 + and IL-4 + lymphocytes (Higuchi et al. 1997 , Reis et al. 1997 . Again, CD8 + CTL are suggested to be likely the major effectors of pathogenesis, contributing to the development of fi brosis in response to cytopathology (Brener and Gazzinelli 1997).
To sum up, until recently, autoimmunity was believed to be the primary mechanism of chagasic disease development. A variety of autoantigens have been described and autoimmune-mediated processes have been demonstrated in experimental models (Leon et al. 2001 , Pontes-de-Carvalho et al. 2002 . Increasingly, with the demonstration of parasite antigens in the heart tissue, parasite persistence has gained favor among several investigators. We surmise that the contribution of parasite persistence, auto-antigens and chronic inflammation is not mutually exclusive and all these mechanisms may contribute, in part, to pathogenesis of CCM. The mechanistic studies identifying i) the mediators produced by cardiomyocytes in response to T. cruzi infection, that may trigger the migration of leukocytes and other cells to the heart; ii) the signaling mechanisms regulated by the inflammatory cytokines (e.g. TNF-α and IL-1) that may evoke cell survival/cell growth or cell death responses in chagasic myocardium; and iii) the destructive effects of " oxidative burst" of activated inflammatory cells in CCM would be discussed elsewhere.
VASCULAR MEDIATORS IN ENDOTHELIUM
In addition to cardiomyocytes, T. cruzi infects endothelial cells in the heart. The role of vascular mediators e.g. endothelin-1 (ET-1) and thromboxane A 2 (TXA 2 ) in CCM has recently been explored (Petkova et al. 2001) . ET-1 is a vasoconstrictor produced by endothelial cells as well as cardiomyocytes and other cell types (Yanagisawa et al. 1988) . Its synthesis by endothelial cells is increased during in vitro infection with T. cruzi (Wittner et al. 1995) and in the myocardium of infected mice (Petkova et al. 2000b ). This appears to be regulated by the transcription factors, NFκB (Huang et al. 1999) and AP-1, in conjunction with the MAPK signal transduction pathway (Miyauchi and Masaki 1999, Petkova et al. 2000a) . T. cruzi infected endothelial cells have also been shown to induce cytokine gene expression (Tanowitz et al. 1992 ). This may contribute to CCM development, as cytokines stimulate ET-1 production (Kurihara et al. 1989 , Martins et al. 1998 . TXA 2 induces vasospasm and platelet aggregation, which is observed in CCM (Rossi and Ramos 1996). Thus, TXA 2 and ET-1 may potentiate CCM by promoting microvascular pathology, e.g., vasospasm, focal ischemia and microthrombi (Petkova et al. 2001) . Vascular mediators, in conjunction with cytokines induced by T. cruzi infection, may be signifi cant to the development of microcirculatory abnormalities that are well documented in CCM.
OXIDANTS, ANTIOXIDANTS AND OXIDATIVE STRESS (AN OVERVIEW)
REACTIVE OXYGEN SPECIES (ROS) AND REACTIVE NITROGEN SPECIES (RNS)
Broadly defi ned, ROS are derivatives of molecular oxygen (O 2 ) (Nordberg and Arner 2001), e.g. su-
2 ), hydroxyl radical (HO · ), and hydrogen peroxide (H 2 O 2 ). ROS are produced through the action of specifi c oxidases and oxygenases, the Fenton reaction and are also by-products of the electron transport chain (Turrens 2003 (Turrens , 2004 . RNS include · NO and its derivatives. · NO is produced by the enzymatic activity of NOS. Different NOS isoforms have been identifi ed in the cytoplasm (iNOS), in mitochondria (mtNOS), or in specifi c cell types e.g. endothelial NOS (eNOS) (Andrew and Mayer 1999 (Figure 1 ).
SOURCES OF ROS
Oxidases and oxygenases
Numerous oxidases and oxygenases expressed in different cell types and locations within the cell contribute to the formation of ROS. By defi nition, oxidases reduce O 2 whereas oxygenases (oxidoreductases) transfer O 2 to substrates. ROS production, termed the " oxidative burst" of activated phagocytic cells e.g. macrophages and neutrophils, results from NADPH oxidase and/or by myeloperoxidase activity (Halliwell 1991 , Eiserich et al. 2002 . This ROS production is critical to anti-microbial function, contributing either directly or indirectly to the killing of intracellular organisms. Myeloperoxidase, produced by neutrophils, converts H 2 O 2 and chloride ions into hypochlorous (HOCl) acid (Winterbourn et al. 2000) . Other oxidases are more generally expressed in mammalian cells but differ in their basal level of expression and subcellular locations. Monoamine oxidase, present in the outer mitochondria membrane, converts O 2 to H 2 O 2 on the cytoplasmic face (Hauptmann et al. 1996) . Both xanthine oxidase and xanthine dehydrogenase, derived from xanthine oxidoreductase, produce H 2 O 2 and O ·− 2 in the process of degrading the purine hypoxanthine to uric acid (Berry and Hare 2004) . In rats and some lower eukaryotes, xanthine oxidase is demonstrated to be both cytoplasmic and peroxisomal. O ·− 2 may also be produced by lipoxygenase, cyclooxygenase (McIntyre et al. 1999 ) and cytochrome P450-dependent oxygenases (Coon et al. 1992) .
Fenton chemical reaction
Besides production by oxidases and oxygenases, the Fenton reaction is another mechanism of ROS formation. This reaction results in the Fe +2 -or Cu + -mediated conversion of H 2 O 2 to HO · (Goldstein et al. 1993) .
Electron transport chain (ETC)
Mitochondria are considered a major source of ROS production in heart (Loschen et al. 1971 
GPx (Prx)
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ANTIOXIDANTS
The overall level of cellular ROS is determined by the relative rate of generation and the rate of reduction by antioxidants. We discuss the enzymatic and non-enzymatic antioxidants that appear to be most important in scavenging myocardial ROS (Figure 1 ).
Enzymatic antioxidants
Enzymatic antioxidants are expressed in response to ROS production and function as catalysts in reactions that convert specifi c ROS to different and, presumably, less harmful species. 
Lipid peroxidation (LPO)
Lipid peroxidation is the major biochemical consequence of oxidative deterioration of polyunsaturated lipids in cell membranes and causes damage to membrane integrity and loss of membrane protein function. 
DNA damage
DNA can be oxidized by a variety of mechanisms, resulting in nucleotide damage e.g. formation of 8-oxoguanine lesions. As a result, DNA replication may be inaccurate leading to mutations and transcription errors. While mechanisms exist to repair these DNA lesions, the level of DNA damage may exceed the capacity of the cellular repair mechanisms. Furthermore, mtDNA is believed to be particularly susceptible to sustained damage, since mitochondria may lack appropriate DNA repair mechanisms (Evans and Cooke 2004) .
MITOCHONDRIAL ABNORMALITIES AND OXIDATIVE STRESS IN CCM
Oxidative stress is generally viewed as a protective defense mechanism employed by the host to control parasitic infection. There is, however, growing evidence to suggest that sustained oxidative stress may contribute to CCM pathology. Pathogen invasion-and replication-mediated cellular injuries and immune-mediated cytotoxic reactions are the common source of ROS in infectious etiologies. As mentioned in section " Immune responses: Protective or pathological", experimental studies have shown that T. cruzi infection elicits inflammatory cytokines, NO production, and oxidative burst, all of which, though essential for controlling acute parasitemia, may have toxic effects on host cellular components and be of pathological signifi cance in CCM. Mitochondria represent 30% of the total volume of cardiomyocytes and provide ∼90% of the cellular energy through the oxidative phosphorylation pathway. As discussed in section " Electron transport chain (ETC)", the CI and CIII complexes of the respiratory chain are the prime site for electron leakage to oxygen, and free radical production in mitochondria. The rate of mitochondrial ROS release is inversely proportional to the rate of electron transport, exponentially increasing when CI or CIII complexes of ETC function at a suboptimal level (Ide et al. 1999 , Wallace 2000 , Lesnefsky et al. 2001 , Chen et al. 2003 . Interestingly, mitochondria are targets to a variety of endogenous and exogenous insults that may affect ETC function. Further, CI and CIII are redox sensitive, as they contain Fe 4 S 4 clusters which when oxidized, release one iron atom, resulting in the inactivation of important functional Fe-S centers and enzyme activity. The released ferrous ions, when participating in the Fenton reaction, produce highly reactive HO ·− radicals. Consequently, ROS as a by product of respiratory chain is considered the major source of free radicals in the heart and mitochondrial dysfunction-mediated oxidative stress has been shown in many cardiac pathologies (Sawyer et al. 2002) . The importance of these fi ndings as it relates to chagasic disease is that an early and consistent repression of CI and/or CIII activities associated with sustained oxidative stress is shown in mitochondria isolated from the myocardium of mice infected by T. cruzi . A consistent decline in MnSOD activity, the major oxygen radical scavenger in the mitochondrial matrix, during progression of infection and disease in chagasic myocardium was also shown (Wen et al. 2004 ). These studies have led to the suggestion that a catastrophic cycle of mitochondrial functional decline and ROS generation, coupled with an inability to effi ciently scavenge the mitochondrial ROS (due to MnSOD defi ciency), predisposes the chagasic hearts to sustained oxidative stress during infection and disease development. We discuss the literature related to role of mitochondrial dysfunction and inadequate antioxidant defenses in sustaining the oxidative stress in CCM.
MITOCHONDRIAL DYSFUNCTION IN CCM
The early insights suggesting mitochondrial alterations in CCM were provided by electron microscopic analysis of biopsies from cardiac tissue of chagasic patients (Carrasco Guerra et al. 1987 , Palacios-Pru et al. 1989 , Parada et al. 1997 ) and experimental models (Uyemura et al. 1995 , Garg et al. 2003 . Microscopic examination of biopsy samples from the patients showed that degenerative myocardial changes occur very early during the indeterminate phase and become more pronounced with increased severity of clinical disease. In experimental models of chagasic disease, the ultrastructural evaluation of the morphological alterations in the myocardium has illustrated an accumulation of large, irregular nuclei, swollen and displaced mitochondria, and myofi brillar degeneration, that progress in parallel with the severity of disease (Garg et al. 2003) . These studies have revealed two important observations. First, nuclear and mitochondrial structural damage occurs much earlier than do the clinical symptoms of disease. Second, the severity of these aberrations increase with the evolution of chronic disease. Jointly, these observations imply that a correlation exists between the extent of specifi c organelle abnormalities and clinical severity of chagasic disease.
Recent molecular studies have profi led the changes in mitochondrial function-related gene expression in experimental models of T. cruzi infection and disease development (Garg et al. 2003 , Mukherjee et al. 2003 ). These studies utilized global and custom-designed arrays and confi rmed the array data by traditional and real-time RT-PCR and Northern blotting approaches. The overall picture that emerged from these studies was that the myocardial transcripts encoding metabolic enzymes involved in fatty acid β-oxidation were upregulated, while the mRNAs for a majority of the subunits of the complexes of the ETC pathway were repressed in response to infection. It is important to note that the mtDNA-encoded transcripts for the subunits of the ETC complexes were repressed in response to infection , before the alterations in nDNA-encoded transcripts were detected. The expression level of mtDNAencoded ETC components that were examined (9 of 13) as substantially reduced (up to 80%) with progression to chronic disease phase. A loss in mtDNA-encoded transcripts (and presumably proteins) below the threshold level is likely to result in a defi ciency of respiratory complexes in chagasic hearts.
We and others have demonstrated a substantial decline in respiratory chain complexes CI, CIII, and CV activities in the myocardium of infected experimental animals (Uyemura et al. 1995 . Along with a decline in total specifi c activity of respiratory complexes (determined by spectrophotometry assays), inactivation of the assembled complexes (determined by catalytic staining on blue-native gels) was also noted, suggesting that multiple mechanisms are likely to be involved in inhibition of the respiratory complexes in the chagasic myocardium. Interestingly, the fi nding of a loss in CI activity early in response to parasite infection led to a suggestion that CI might be the potential site for ROS generation in acute murine myocardium. CIII defi ciencies were consistent in cardiac mitochondria, but were not observed in skeletal muscle mitochondria at all stages of infection and disease progression, leading to an implication that CIII is the likely site for sustained ROS generation in chagasic myocardium . Future studies would, hopefully, address the pathophysiological signifi cance of mtROS in CCM.
In human patients, direct demonstration of mitochondrial dysfunction awaits further investigation. However, biochemical analysis have provided indirect evidence to suggest mitochondrial abnormalities in chagasic patients. For example, Carrasco et al. showed a reduction in the activities of succinate dehydrogenase and myosine ATPase by histochemical staining of small endomyocardial biopsies obtained from the chagasic patients (Carrasco Guerra et al. 1987) . The histochemical alteration index, while increased in seropositive patients in the so-called " indeterminate" phase, was highest in chronic patients. In another study of chagasic patients, changes in the serum pattern of metabolic enzymes was documented (Alarcon-Corredor et al. 2002) . The main fi nding in this study was a substantial increase in glutamate-oxaloacetate transaminase (GOT) and 3-hydroxy butyrate dehydrogenase (HBDH) activity. Importantly, high serum levels of GOT and HBDH were detected in indeterminate patients, and remained consistently high in patients advancing to clinical cardiac dysfunction. Considering the site (coronary sinus) and the extent of release of GOT and HBDH in indeterminate-to-chronic patients, it was surmised that mitochondrial and cell membrane injuries are the earliest events in chagasic disease, and the degenerative mitochondrial and cellular events persist with advanced disease. The detection of inorganic phosphorus and isocitrate dehydrogenase molecules in the serum of indeterminate patients, followed by a positive coronary sinusfemoral artery inorganic phosphate gradient with advancement of chronic disease further supports the hypothesis of very early and progressive manifestations of mitochondrial metabolic abnormalities in chagasic myocarditis . Collectively, these studies support the hypothesis that mitochondrial metabolic abnormalities are manifested very early in infection and exacerbated during CCM progression.
FACTORS CONTRIBUTING TO MITOCHONDRIAL DYSFUNCTION
T. cruzi infection elicits substantial biochemical, molecular and immunological insults all of which may adversely affect mitochondria in chagasic myocardium. Invasion by parasite elicits transient elevations in intracellular Ca +2 (Burleigh and Andrews 1995) followed by release of the parasite from the parasitophorous vacuole. The acute phase of infection is then marked by massive replication of the parasite in host cell cytoplasm and activation of potent inflammatory reactions (section " Immune responses: Protective or pathological"). In mammalian cells, Ca +2 overload is known to induce the opening of mitochondrial permeability transition pores, leading to dissipation of the proton gradient (Korge et al. 2001 , Kanno et al. 2002 . Given, that maintenance of mitochondrial membrane potential and ion transport is essential for oxidative phosphorylation it is likely that T. cruzi-induced Ca +2 overload might be the primary signal in mitochondrial dysfunction. This notion is supported by others, who indicate that the elevated levels of Ca +2 contribute to impairment of mitochondrial respiratory enzyme activity (Medrano and Fox 1994, Liang and Molkentin 2002) .
Following initial injuries, it is likely that mitochondria may be damaged by ROS originated via inflammatory mechanisms or respiratory chain impairment. The fi rst evidence of oxidative damage to mitochondria was reported utilizing an experimental model of infection and chronic disease . This study demonstrated a substantial increase in LPO and PCO derivatives in cardiac mitochondria of infected mice, compared to controls. The LPO derivatives of mitochondrial membranes were detectable as early as 3 days post-infection, and gradually increased by >2-fold during the course of disease development. The PCO content in cardiac mitochondria became evident during the acute infection phase and remained consistently enhanced throughout the chronic phase of disease progression. ROS-induced LPO and PCO derivatives deposition in mitochondrial membranes is shown to cause increased permeability and loss of mitochondrial membrane potential and protonmotive force (Piper et al. 1994 , Vercesi et al. 1997 , Cardoso et al. 1999 . We anticipate future studies would delineate the mechanistics of mitochondrial oxidative modifi cations of membrane lipids and proteins in alterations of mitochondrial integrity, dissipation of the mitochondrial membrane potential and protonmotive force, and respiratory chain ineffi ciency in CCM.
Direct oxidative modifi cation of specifi c subunits of respiratory complexes may be an underlying means of inactivation of assembled mitochondrial complexes in chagasic hearts . Cardiac mitochondria from infected mice were subjected to two-dimensional blue-native gel electrophoresis to resolve the subunits of the respiratory complexes. Carbonylated subunits derivatized with dinitrophenylhydrazine were then detected by immunoblotting and identifi ed by N-terminal Edman sequencing. On the basis of the identity of subunits that were oxidatively modifi ed, different mechanisms were proposed to participate in inactivation of CI and CIII respiratory complexes in chagasic hearts. Of the >42 subunits of CI, carbonyl adducts were primarily detected with NDUFS1, NDUFS2, and NDUFV1, the core subunits of CI complex (Papa et al. 2002 , Carroll et al. 2003 . Considering that genetic mutations in genes encoding NDUFS1 (Benit et al. 2001 ), NDUFS2 (Loeffen et al. 2001 ), and NDUFV1 (Schuelke et al. 1999 and oxidation/nitration of NDUFS2 (Murray et al. 2003 ) are linked to CI defi ciencies in human and bovine hearts, it was surmised that oxidatively modifi ed structural subunits contribute to the inactivation of the assembled CI complex in chagasic hearts. Among the 11 components of CIII, consistent carbonylation of core proteins (UQCRC1 and most likely UQCRC2), thought to be involved in the cleavage and processing of the targeting presequence of Reiske 2 Fe-2S protein (ISP) (Iwata et al. 1998) , was noted in chagasic hearts. The inappropriate processing of ISP by oxidatively modifi ed core proteins may result in incorporation of the misfolded ISP in CIII. Ultimately, the consequences would potentially be the mis-assembly of the catalytic site and inhibition of the enzymatic activity of complex. Further studies would confi rm the mechanistics of oxidative stress-induced CI and CIII inactivation in CCM. Nevertheless, the observation of dose-dep endent HNE-mediated inhibition of respiratory complexes in the same study supports the idea that oxidative modifi cations contribute to inactivation of respiratory complexes in chagasic myocardium.
In chronically infected murine hearts, a substantial depletion of mtDNA was demonstrated and in addition was associated with reduced levels of mtDNA-encoded transcripts. These observations imply that a limited biosynthesis of mitochondriaencoded protein subunits may contribute to reduced assembly of respiratory chain complexes in chagasic myocardium . What may cause mtDNA depletion in chagasic myocardium is not known. Numerous studies strongly support reactive species as playing a prominent role in mtDNA deletions through oxidative damage. Under conditions of oxidative stress, accumulation of signifi cantly higher levels of DNA oxidation product 8-hydroxydeoxyguanosine in mtDNA compared to nuclear DNA and increased degradation of the mutated mtDNA is shown in a variety of in vitro and in vivo conditions (Palmeira et al. 1997 , Williams et al. 1998 , Serrano et al. 1999 . It is postulated that increased ROS production may lead to mutations and eventually degradation of oxidatively damaged mtDNA, thus accounting for decreased assembly and activity of respiratory complexes in chagasic myocardium.
Taken together, in the animal model of CCM, mitochondria dysfunction was evidenced at RNA, protein, and possibly DNA levels using several experimental approaches while indirect evidence for mitochondrial dysfunction are provided in human patients. Increased LPO and PCO deposition in mitochondria with disease severity, and oxidative modifi cations of subunits of the mitochondrial complexes provide strong evidence in support of sustained oxidative stress of mitochondrial origin in chagasic hearts. Future studies would determine whether impaired mitochondrial tolerance due to oxidative stress result in increased vulnerability of mitochondrial DNA and energetics and thereby constitute a mechanism in myocardial dysfunction in CCM.
INADEQUATE ANTIOXIDANT RESPONSE AND OXIDATIVE DAMAGE IN CHAGASIC HEARTS
The data discussed so far provides evidence to support the idea that chagasic hearts are likely to be exposed to ROS of inflammatory and mitochondrial origin. The myocardium contains high concentrations of various non-enzymatic and enzymatic scavengers of ROS (Antioxidants) which protects from oxidative damage. However, ROS production may overwhelm the ability of the cell to detoxify these radicals, resulting in ROS-induced oxidative stress. The myocardial cells, when oxidatively stressed, may exhibit saturation of the antioxidant defenses, loss of intracellular redox homeostasis, alterations in cellular signaling, and induction of pathological processes (Hensley et al. 2000 , Martindale and Holbrook 2002 , Ueda et al. 2002 . A series of recent studies have addressed the oxidative status and antioxidant defense capabilities during the course of infection and progression of chagasic disease in human patients and experimental models. The demonstration of a selenium defi ciency that increased with severity of chronic disease in chagasic patients was probably the fi rst observation suggesting that antioxidant defi ciencies may be related to the progression of disease pathology. Further studies in experimental CCM models showed that seleniumdepletion was associated with increased susceptibility, myocarditis severity, and heart damage (Gomez et al. 2002) , leading to higher mortality rate (de Souza et al. 2002) . The myocardial damage in infected mice was arrested or reversed upon dietary supplementation with low doses of selenium (de Souza et al. 2003) . In other studies, the detection of inflammatory cytotoxic mediators (TNF-α and NO) along with a reduction in plasma levels of GPx and SOD in patients led to a suggestion that an oxidant/antioxidant imbalance might drive the chagasic disease pathology (Perez-Fuentes et al. 2003) . We have shown in an animal model that when antioxidant defense responses (constituted by GPx, GR, and GSH) were of suffi cient magnitude (e.g. in skeletal muscle), T. cruzi-induced oxidative stress and damage was controlled ). However, myocardium appeared to be poorly equipped with antioxidant defenses. In response to T. cruzi, a transient increase in antioxidant enzyme activities (GPx, GR) and reductant (GSH) level was noted in the myocardium of acutely infected mice. However, these antioxidants were static (similar to control level) or decreased during disease development. Consequently, myocardium of infected animals sustained oxidative damage evidenced by consistent increase in oxidative stress biomarkers (LPO, PCO, GSSG) during the course of infection and chronic disease . It was concluded that the glutathione antioxidant reserve is not depleted in the myocardium, but is not adequate to limit oxidative stress-induced damage during CCM development.
Finally, a consistent decline in MnSOD activity with progression of infection and disease is shown in a murine model . MnSOD coupled with GPx (mitochondrial and cytosolic) and CAT (cytosolic) is important in minimizing O ·− 2 and H 2 O 2 levels in the heart. When produced in excess, or when MnSOD activity is not suffi cient, O2 ·− participates in iron-catalyzed pathways forming highly reactive and damaging · OH for which no antioxidant enzyme system exists (Tokoro et al. 1996) . Additionally, O ·− 2 enhances the toxicity of phagocyte-induced NO that is elicited for parasitic control in an infected host, by forming peroxynitrite (ONOO -) (Sato et al. 1993 ). Both ONOO -and · OH are known to induce substantial tissue injury and dysfunction by virtue of their ability to nitrosylate and/or oxidize biomolecules (Ide et al. 2001 , Katsanos et al. 2002 . Authors deduced that repression of MnSOD's protective ability contributes to oxidative modifi cations and dysfunction of respiratory complexes which could lead to a vicious cycle of uncontrolled ROS production. This hypothesis is supported by the observations of a decrease in CI complex-mediated respiration, and an increase in oxidative damage, DNA fragmentation, and cytochrome c release in MnSOD -/+ mice which exhibit a 50% reduction in MnSOD activity compared to normal controls ( Williams et al. 1998 , Van Remmen et al. 2001 . In MnSOD -/-mice neonatal lethality associated with the development of dilated cardiomyopathy and mitochondrial dysfunction provides further evidence for the importance of MnSOD activity in maintaining the integrity of the mitochondrial enzymes susceptible to direct inactivation by O ·− 2 (Li et al. 1995) .
SUMMARY
Sustained ROS generation (of inflammatory and mitochondrial origin) coupled with inadequate antioxidant response resulting in ineffi cient scavenging of ROS in the heart leads to long-term oxidative stress and subsequently oxidative damage of the cardiac cellular components during chagasic disease. Future studies testing the usefulness of therapies capable of enhancing mitochondrial function, antioxidant effi ciency, or ROS scavenging in combination with anti-parasite drugs will provide convincing evidence to link oxidative stress as a causative mechanism in the development of CCM.
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